ABSTRACT We have examined the expression pattern of the avian Meox1 homeobox gene during early development and up to late limb bud stages. Its expression pattern indicates that it is involved in somite specification and differentiation. The domains of expression are similar but different to those of Meox2. Meox1 is expressed from stage 6 in the pre-somitic mesoderm and as development proceeds, in the tail bud, the dermomyotome of the rostral somites and in the dermomyotome and sclerotome of the caudal somites, the lateral rectus muscle, truncus arteriosus of the heart and the limb buds. Unlike Meox1, Meox2 is not expressed in the pre-somitic mesoderm, but is expressed first in somites formed from stage 11 onwards. In the developing limb, both genes are expressed in the dorsal and ventral limb mesoderm in adjacent domains with a small region of overlap. In the limb bud, Meox1 is co-expressed with Meox2 but neither Meox gene is co-expressed with MyoD. These expression patterns suggest that these two genes have overlapping and distinct functions in development.
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Meox1 and Meox2, formerly known as Mox1 and Mox2, are closely related homeobox genes with mesoderm and mesenchyme specific expression during mouse embryonic development (Candia et al., 1992) . Mice homozygous for a null mutation of Meox2 have defects in limb muscle differentiation resulting in an overall reduction in muscle mass and absence of specific muscles (Mankoo et al., 1999) . Meox1 mutant mice exhibit mild defects in sclerotome-derived vertebral and rib bones (Mankoo et al., unpublished) . Compound mutant embryos (Meox1 -/-;Meox2 -/-) displayed a dramatic phenotype associated with disrupted somite development; the axial skeleton failed to develop and most skeletal muscles were absent or reduced in size (Mankoo et al., 2003) . These studies demonstrated that Meox 2 is required for limb muscle development and both Meox1'and Meox2 have a critical concerted function during somite morphogenesis (Mankoo et al., 2003) . To understand the function of these two transcription factors during chick embryogenesis requires a detailed knowledge of their expression at relevant stages of development.
In chick, Meox2 expression during development has been previously described (Rallis et al., 2001) . Here, we describe for the first time in chick the distribution of Meox1 and compare it to Meox2. Meox1 has both unique and overlapping expression domains with Meox2 in chick and similar but not identical expression patterns to Meox1 in mouse.
A chicken Meox1 cDNA clone, ChEST805f3, was obtained from the BBSRC Chicken EST Project (Hubbard et al., 2005) . The nucleotide sequence homology of this clone showed 86% identity to human Meox1 and 86% to murine Meox1.
Meox1 expression first appears in the chick embryo at the time of formation of the headfold (stage 6, Hamburger and Hamilton, 1951) in the pre-somitic mesoderm (Fig. 1A) . Expression in this domain continues through stage 7 (Fig. 1B) and at stage 8 is in the pre-somitic mesoderm and the first somites (Fig. 1C) . A section through the embryo in Fig. 1B confirms that expression of Meox1 is in the pre-somitic mesoderm (psm, Fig. 1E , red arrows) and not in the ectoderm and endoderm. In the initial epithelial stage, the entire somite expresses Meox1. In mouse, like chick, Meox1 expression begins during the gastrulation stage (E7.0-7.5) in the posterior mesoderm (Candia et al., 1992) . At stage 10, Meox1 expression is located in the developing somites and the most anterior pre-somitic mesoderm. There is strong expression in the posterior somites but the signal rapidly diminishes in the more rostral somites (Fig. 1D) . By stage 14 chick Meox1 expression is much stronger in the pre-somitic mesoderm and the most caudal somites suggesting a role for this gene in somite formation and differentiation (Fig. 1F, black arrow) . The most anterior somites also show higher expression levels and correspond to cervical somites (Fig. 1F , CS, black band). The thoracic somites initially have high Meox1 expression, but as they mature this drops to a much lower level (Fig. 1F , TS, black band). Murine Meox1 expression at neurulation stages (E8.0-9.5) is described in intermediate and lateral plate mesoderm (Candia et al., 1992) . In chick, in contrast, Meox1 was not detected in intermediate and lateral plate mesoderm (Figs. 1H and 1I).
As previously described by Rallis and colleagues (Rallis et al., 2001) , the onset of Meox2 expression (Fig. 1J) is at stage 11 in all cervical somites, far later than that of Meox1. This is in contrast with murine Meox2 which is expressed from E8.0 onwards in all newly formed somites. At stage 16, unlike Meox1, Meox2 expression is not detected in the pre-somitic mesoderm and is first seen in newly formed epithelial somites (compare Figs. 1G, red arrow with 1K, red arrow). Furthermore, Meox2 expression is maintained at a high level in the somites unlike Meox1 which decreases in mature somites. A transverse, vibratome section through the caudal somites of the stage 16 embryo in figure 1G (plane of section shown by black line, H) shows that Meox1 expression is in both the dermomyotome and sclerotome (dm and scl, red arrows, Fig. 1H ). The dermomyotome gives rise to muscle and dermis and the sclerotome to cartilage and vertebrae. Figure  1I shows a more rostral, transverse section through the embryo in figure 1G (plane of section shown by black line I) and reveals that Meox1 expression is restricted to the dermomyotome (red arrow). At E9.5 the murine Meox1 signal is detected in the dermomyotome and the sclerotome (Candia et al., 1992) . Chick Meox2 is detected in the whole somite as shown by a transverse section through a stage 16 chick embryo (Fig. 1L ). There is also expression in the developing mid-gut (Fig. 1L , mg, black arrow).
Expression in stages 17-25 emphasises differences between

Meox1 and Meox2
In chick, there are very few changes in the expression of Meox1 from stage 16 to 20. At stage 17 Meox1 begins expression in the lateral rectus muscle of the eye and at stage 20, ( Fig. 2A) , the muscle precursors of the first pharyngeal arch. Its somitic expression is restricted to the posterior halves, strong expression continues in the tailbud and in the lateral rectus muscle, clearly visible in a region lateral to the eye. (Fig. 2A) . A close-up of the head of the stage 20 embryo in Fig. 2A shows Meox1 expression in the lateral rectus muscle (Fig. 2J , red arrow) and the first pharyngeal arch (Fig. 2J, black arrow) . A close-up of the somitic domain confirms that Meox1 expression is restricted to the posterior halves of the somites (Fig. 2L , red arrow). At stage 22, chick Meox1 expression is first detected in the fore limb buds (Fig. 2B , red arrow) and continues in the eye region (Fig. 2K ) At stage 25, expression continues in the eye domain, somites, tail bud and the limb buds signal is stronger (Fig. 2C , red arrows). Extended staining revealed additional sites of expression (Fig. 2D) namely the oesophagus (o), truncus arteriosus of the heart (ta) and the dorsal somites (black arrow). As in chick, the mouse Meox1 signal at E11.5 is also detected lateral to the eye (Fig. 2G, upper red arrow) . At E11.5 murine Meox1 expression is similar to chick expression in the somites with stronger expression in the caudal somites and expression begins in the limb bud (Fig. 2G ) and the pharyngeal arches (Fig. 2G, lower red arrow) . At later stages, murine Meox1 expression has also been reported to be localised to regions of the developing heart (truncus arteriosus) (Candia et al., 1992) . From stages 16 to 20, the chick Meox2 signal, like Meox1, does not dramatically change. At stage 20 Meox2 expression is found in the posterior halves of the somites, similar to Meox1 (Fig. 2E) . In limb buds, Meox2 expression is first observed in stage 21 chick embryos (this study and Rallis et al., 2001) . A lateral view of a stage 25 chick embryo shows strong Meox2 expression in the developing limb buds (Fig. 2F, red arrows) and expression continues in the somites (Fig.  2F) . A new domain of expression begins at this stage, the 2 nd pharyngeal arch (Fig. 2F, white arrow) . In chick, unlike Meox1, there is no Meox2 expression detected in the heart. Stage 25 chick embryos were hybridised with Pax3 for comparison with Meox1 and Meox2 expression in the somites. Figure 2H shows Pax3 expression in the limbs at stage 25 and is expressed in the epithelial dermomyotome with strong expression in the ventral domain of the somites. Scleraxis expression at stage 25 in the chick is in the limb buds and the intersomitic mesenchyme (Fig. 2I ).
Expression in stage 22 and 25 hind limb buds
Avian Pax3 (Goulding et al., 1994) (Fig. 3C ) MyoD (Fig. 3D) , Myf5 (Fig. 3E ) and the tendon marker, Scleraxis (Scx, fig. 3F ) can be seen. 
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This is in contrast to the expression of Scleraxis at stage 25 in the somites -Scleraxis is expressed in the syndetome -and the limb buds. Abbreviations: dpm, dorsal pre-muscle mass; vpm, ventral pre-muscle mass.
central core of the hind limb but sectioning at the limb level did not show evidence of staining in limb muscle progenitors migrating from the dermomyotome (Fig. 3G, left  side) . At stage 25, expression is still detected in the dermomyotome and there is now strong expression in the dorsal and ventral limb mesoderm, apparently overlapping with the dorsal and ventral premuscle masses (dpm, vpm, Fig. 3G , right side). At stage 22, Meox2 positive myoblasts are migrating from the dermomyotome into the dorsal and ventral hind limb (Fig. 3H, left side) . At stage 25, Meox2 transcripts are observed in the dermomyotome and in the same region as the dorsal and ventral pre-muscle masses (Fig. 3H, right side) . Transverse sections of stage 25 hind limbs were in situ hybridised with myogenic markers MyoD (Fig. 3I) , Myf5 (Fig. 3J) and Pax3 (Fig. 3K) . These show that Meox1 and Meox2 transcripts appear to localise to the same domains as these myogenic marker genes, namely the dermomyotome and the dorsal and ventral pre-muscle masses. The domains of Scleraxis expression are slightly different at stage 25 (Fig. 3L) . In the somite it is located to the syndetome and the limb, in cells beginning to coalesce into tendon precursors.
In the developing mouse embryo limb buds at E9.75 and E10.75, Meox2 is expressed in the somite derived myoblasts that coalesce to form the dorsal and ventral pre-muscle masses; Meox1 mRNA was not detected in the limb bud at these stages (Mankoo et al., 1999) . We detected low levels of the Meox1 signal at E11.5 in the limb buds in the dorsal and ventral mesenchyme (data not shown).
To determine the identity of the cells in the dorsal and ventral pre-muscle mass regions that express Meox1 and Meox2, two-colour fluorescence labelled in situ hybridisation was performed on transverse cryosections of stage 25 chick limbs. Figproximal limb domain, the two expression domains overlap but there is no co-expression (see Fig. 4L , inset). Meox2 (Fig. 4M , green) and Meox1 (Fig. 4N, red) have abutting domains of expression with regions of overlap but Meox2 is expressed in a more peripheral, broader domain in the dorsal and ventral limb mesenchyme than Meox1 and there is a narrow region of overlap where both genes are co-expressed (Fig. 4O, white line) . Table 1 compares the similarities and differences between the expression domains of Meox1 and Meox2 in chick and mouse at equivalent developmental stages.
Summarising, chick Meox1 and Meox2 have similar but distinct spatial-temporal expression patterns during early devel- Meox1 has strong expression in the pre-somitic mesoderm whereas Meox2 transcripts are absent in this domain. In the newly formed somites, Meox1 transcripts are detected throughout the somite in the sclerotome and dermomyotome. When the somites differentiate, Meox1 expression is restricted to the dermomyotome. Meox2 is expressed throughout the whole somite and its expression is maintained along the axis whereas Meox1 expression is strongest in most caudal somites and is much reduced more anteriorly. Both genes appear conserved between chick and mouse. In the chick limb, two-colour fluorescent in situ hybridisation revealed that neither Meox1 nor Meox2 transcripts had overlap with MyoD expressing cells. This technique also revealed that chick Meox1 and Meox2, although both being expressed in the same regions as the dorsal and ventral pre-muscle masses, show only a small domain of co-expression. Meox1 and Meox2 have overlapping domains of expression which suggest overlapping functions. However, within developing somites and the limb bud the non-overlap of expression indicates these genes have distinct and unique functions.
Experimental Procedures
Fertilized chicken eggs were staged according to Hamburger and Hamilton (Hamburger and Hamilton, 1951) .
Full-length chick Meox2 cDNA was cloned in pBluescript KS (+/-) (Stragene) and to generate digoxigenin (DIG) labelled (Roche) antisense probe, cut with SacI and transcribed with T3 RNA polymerase (Roche). Scleraxis anti-sense probe was generated from ChEST973H2 cDNA from the BBSRC Chicken EST Project, cloned into pBluescript KS II, cut with Not1 and transcribed with T3. Meox1 antisense-probe was generated from ChEST805F3, cloned into pBluescript KS II, cut with NotI and transcribed with T3. MyoD, Pax3 and Myf5 anti-sense probes were a kind gift of Philippa Francis-West. Full-length mouse Meox1 cDNA was cloned into pBluescript KS II, cut with PstI and transcribed with T3. Wholemount in situ hybridisation was carried out using standard procedures.
Two-colour fluorescence in situ hybridisation was performed on fresh frozen sections as described by Tylzanowski et al. (2003 TABLE 1 probes were used instead of biotin-labelled probes and detected by anti-FITC-POD (Roche 1426346). Proteinase K digestion at 1µg/ml for 5-7 mins was used for tissue permeabilisation.
COMPARISON OF MEOX1 AND MEOX2 EXPRESSION PATTERNS IN CHICK AND MOUSE DURING EARLY EMBRYOGENESIS
